Crossmark

Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model

Crossref DOI link: https://doi.org/10.1038/cddis.2016.11

Published Online: 2016-02-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qiao, H

Wang, T-y

Yu, Z-f

Han, X-g

Liu, X-q

Wang, Y-g

Fan, Q-m

Qin, A

Tang, T-t
License Information

Text and Data Mining valid from 2016-02-11

Version of Record valid from 2016-02-11
More Information

Article History

Received: 25 October 2015

Revised: 4 January 2016

Accepted: 5 January 2016

First Online: 11 February 2016

Competing interests

: The authors declare no conflict of interest.

Retraction Retraction dated 2019-05-08

Click to view Retraction: https://doi.org/10.1038/s41419-019-1606-1